Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH

Por Poulin, Y, Crowley, JJ, Langley, RG, Unnebrink, K, Goldblum, OM, Valdecantos, WC
Publicado no J Eur Acad Dermatol Venereol (2014)

Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient‐reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, control...

Por Thaçi, D., Kimball, A., Foley, P., Poulin, Y., Levi, E., Chen, R., Feldman, S.R.
Publicado no J Eur Acad Dermatol Venereol (2016)

A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients...

Por Papp, KA, Barber, K, Bissonnette, R, Bourcier, M, Lynde, CW, Poulin, Y, Shelton, J, Toole, J, Vieira, A, Poulin-Costello, M
Publicado no J Eur Acad Dermatol Venereol (2015)

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

Por Papp, K.A., Barber, K., Bissonnette, R., Bourcier, M., Lynde, C.W., Poulin, Y., Shelton, J., Garces, K., Toole, J., Poulin‐Costello, M.
Publicado no J Eur Acad Dermatol Venereol (2015)

Corticosteroids for critically ill patients: an international survey of intensivists

Por Lamontagne, F, Adhikari, N, Cook, D, Koo, KK, Lauzier, F, Burns, KE, Douglas, I, Turgeon, AF, Quiroz, H, Poulin, Y, Choong, K, Ferguson, N, Kho, ME, Duffett, M, Chant, C, Lesur, O, Meade, MO
Publicado em 2012